Neal Bhatia

11PUBLICATIONS
27CO-AUTHORS
Cancer geneticsAllergyNanotoxicology, health and safetyPredictive and prognostic markersClinical social work practice
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jul 20, 2026
A Discrete Choice Experiment of Clinician Preferences Among Attributes of Approved Janus Kinase Inhibitors for Alopecia Areata.

|Apr 15, 2025
Complete/Near-Complete Itch Response Observed in Patients with Moderate-to-Severe Atopic Dermatitis Initiating Dupilumab: 3-Year, Real-World, Interim Data from the PROSE Registry.

Neal Bhatia, Charles W Lynde, Luz Fonacier

|Jul 22, 2024
Long-term quality of life outcomes from a phase 4 study of tildrakizumab in patients with moderate-to-severe plaque psoriasis in a real-world setting.

Neal Bhatia, Jayme Heim, J Gabriel Vasquez

|Jul 19, 2024
Biomarkers in Cutaneous Keratinocyte Carcinomas.

Erica Montano, Neal Bhatia, Jelena Ostojić

|Apr 04, 2024
Improvements in Psoriasis-Related Work Productivity with Tildrakizumab: Results from a Phase 4 Real-World Study in Patients with Moderate-to-Severe Plaque Psoriasis.

Tina Bhutani, John Koo, Jayme Heim

|May 11, 2023
Quality of life and patient-reported symptoms in a Phase 4, real-world study of tildrakizumab in patients with moderate-to-severe psoriasis: Week 28 interim analysis.

Neal Bhatia, Jayme Heim, Brad Schenkel

Pageof 2

Frequent Collaborators

2 joint publications

Andrew Blauvelt

2 joint publications

Melinda Gooderham

1 joint publications

Dillon J Patel

1 joint publications

Azra Kurbasic